GOFF BRIAN (Chief Executive Officer) sold 9.4% of their position (19.07K shares) of AGIOS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $661.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common stock
Shares
+25.53K
Price / share
—
Trade value
—
% of position
Common stock
Shares
−12.47K
Price / share
$34.71
Trade value
$432.90K
% of position
Common stock
Shares
+13.50K
Price / share
—
Trade value
—
% of position
Common stock
Shares
−6.60K
Price / share
$34.71
Trade value
$228.95K
% of position
Net shares
+19.96K
Net value
-$661.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 4/2/2026 | M · Option Exercise | +25.53K | — | — | 15.5% | 164.55K | 190.08K |
| Common stock Direct | 4/2/2026 | S · Sale | −12.47K | $34.71 | $432.90K | 6.6% | 190.08K | 177.60K |
| Common stock Direct | 4/2/2026 | M · Option Exercise | +13.50K | — | — | 7.6% | 177.60K | 191.10K |
| Common stock Direct | 4/2/2026 | S · Sale | −6.60K | $34.71 | $228.95K | 3.5% | 191.10K | 184.51K |
| Total | +19.96K | -$661.85K | ||||||
Performance share units
Common stock
25.53K shares
Shares
−25.53K
Strike price
Held after
0.00
Exercisable
—
Performance share units
Common stock
13.50K shares
Shares
−13.50K
Strike price
Held after
40.50K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance share units Direct | Common stock25.53K shares | 4/2/2026 | M · Option Exercise | −25.53K | — | 0.00 | |
| Performance share units Direct | Common stock13.50K shares | 4/2/2026 | M · Option Exercise | −13.50K | — | 40.50K |